Vanguard Group’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.6M | Buy |
|
|||||
|
2025
Q2 | $18.5M | Buy |
|
|||||
|
2025
Q1 | $23.4M | Buy |
|
|||||
|
2024
Q4 | $25.9M | Buy |
|
|||||
|
2024
Q3 | $24.8M | Buy |
|
|||||
|
2024
Q2 | $9.55M | Buy |
|
|||||
|
2024
Q1 | $6.34M | Hold |
|
|||||
|
2023
Q4 | $6.42M | Buy |
|
|||||
|
2023
Q3 | $3.96M | Buy |
|
|||||
|
2023
Q2 | $3.45M | Sell |
|
|||||
|
2023
Q1 | $1.42M | Sell |
|
|||||
|
2022
Q4 | $3.51M | Buy |
|
|||||
|
2022
Q3 | $8.29M | Buy |
|
|||||
|
2022
Q2 | $6.77M | Sell |
|
|||||
|
2022
Q1 | $15.8M | Sell |
|
|||||
|
2021
Q4 | $22.6M | Buy |
|
|||||
|
2021
Q3 | $11.4M | Buy |
|
|||||
|
2021
Q2 | $9.11M | Buy |
|
|||||
|
2021
Q1 | $3.27M | Buy |
|